Stocks Fall After Fed Minutes Show Willingness to Taper in June

Cott Corp

RESEARCH ALERT-Cott: CIBC cuts price target Thursday, 2 May 2013 | 1:29 AM ET

*Cott Corp: CIBC cuts price target to $11 from $12; rating sector outperformer. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
MARKET PULSE-Merck, Titan Pharma, Neutral Tandem, Synacor, Brightcove Wednesday, 1 May 2013 | 1:01 PM ET

**MERCK& CO INC, $45.95, down 2 pct. **TITAN PHARMACEUTICALS INC, $0.46, down 73 pct. **NEUTRAL TANDEM INC, $4.57, up 53 pct.
MARKET PULSE-Merck, Titan Pharma, Neutral Tandem, Synacor, Accelrys Wednesday, 1 May 2013 | 11:06 AM ET

**MERCK& CO INC, $44.76, down 5 pct. **TITAN PHARMACEUTICALS INC, $0.34, down 80 pct. U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceuticals and asked for additional data showing it works, the company said.
MARKET PULSE-Merck, Titan Pharma, Neutral Tandem, Mindspeed Technologies Wednesday, 1 May 2013 | 10:12 AM ET

**MERCK& CO INC, $44.76, down 5 pct. **TITAN PHARMACEUTICALS INC, $0.34, down 80 pct. **NEUTRAL TANDEM INC, $4.12, up 38 pct.
BRIEF-Cott says Q1 revenue rose 4 percent to $505 million Wednesday, 1 May 2013 | 8:18 AM ET

*Q1 earnings per share $0.00. *Q1 revenue rose 4 percent to $505 million. *Says share repurchase program for up to 5% of Cott's outstanding common.
BRIEF-Cott U.K. business to buy Calypso Soft Drinks Tuesday, 30 Apr 2013 | 8:56 AM ET

*Announces U.K. reporting segment's planned acquisition of calypso soft drinks.